ENSC
Price
$2.58
Change
+$0.08 (+3.20%)
Updated
Apr 2, 03:05 PM (EDT)
Capitalization
3.51M
NEUP
Price
$5.70
Change
-$0.06 (-1.04%)
Updated
Apr 1 closing price
Capitalization
19.29M
Ad is loading...

ENSC vs NEUP

Header iconENSC vs NEUP Comparison
Open Charts ENSC vs NEUPBanner chart's image
Ensysce Biosciences
Price$2.58
Change+$0.08 (+3.20%)
Volume$100
Capitalization3.51M
Neuphoria Therapeutics
Price$5.70
Change-$0.06 (-1.04%)
Volume$28.29K
Capitalization19.29M
ENSC vs NEUP Comparison Chart
Loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENSC vs. NEUP commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENSC is a Hold and NEUP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ENSC: $2.50 vs. NEUP: $5.70)
Brand notoriety: ENSC and NEUP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENSC: 359% vs. NEUP: 16%
Market capitalization -- ENSC: $3.51M vs. NEUP: $19.29M
ENSC [@Biotechnology] is valued at $3.51M. NEUP’s [@Biotechnology] market capitalization is $19.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENSC’s FA Score shows that 0 FA rating(s) are green whileNEUP’s FA Score has 1 green FA rating(s).

  • ENSC’s FA Score: 0 green, 5 red.
  • NEUP’s FA Score: 1 green, 4 red.
According to our system of comparison, NEUP is a better buy in the long-term than ENSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENSC’s TA Score shows that 3 TA indicator(s) are bullish while NEUP’s TA Score has 4 bullish TA indicator(s).

  • ENSC’s TA Score: 3 bullish, 4 bearish.
  • NEUP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NEUP is a better buy in the short-term than ENSC.

Price Growth

ENSC (@Biotechnology) experienced а -28.57% price change this week, while NEUP (@Biotechnology) price change was +3.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.91%. For the same industry, the average monthly price growth was -7.11%, and the average quarterly price growth was -11.65%.

Reported Earning Dates

ENSC is expected to report earnings on May 15, 2023.

NEUP is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEUP($19.3M) has a higher market cap than ENSC($3.51M). NEUP YTD gains are higher at: 66.181 vs. ENSC (-69.287). ENSC has higher annual earnings (EBITDA): -6.7M vs. NEUP (-14.17M). NEUP has more cash in the bank: 4.35M vs. ENSC (3.5M). NEUP has less debt than ENSC: NEUP (199K) vs ENSC (302K). NEUP has higher revenues than ENSC: NEUP (663K) vs ENSC (0).
ENSCNEUPENSC / NEUP
Capitalization3.51M19.3M18%
EBITDA-6.7M-14.17M47%
Gain YTD-69.28766.181-105%
P/E RatioN/A0.52-
Revenue0663K-
Total Cash3.5M4.35M81%
Total Debt302K199K152%
FUNDAMENTALS RATINGS
ENSC: Fundamental Ratings
ENSC
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENSCNEUP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
ENSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEUP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VST122.244.80
+4.09%
Vistra Corp
ARR17.03-0.07
-0.41%
ARMOUR Residential REIT
PCH44.82-0.30
-0.66%
PotlatchDeltic Corp
STXS1.71-0.05
-2.84%
Stereotaxis
EDUC1.31-0.06
-4.38%
Educational Development Corp

ENSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENSC has been loosely correlated with MLLCF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ENSC jumps, then MLLCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENSC
1D Price
Change %
ENSC100%
-2.34%
MLLCF - ENSC
37%
Loosely correlated
N/A
HNSBF - ENSC
33%
Loosely correlated
N/A
GNPX - ENSC
32%
Poorly correlated
-6.20%
HOWL - ENSC
31%
Poorly correlated
-10.46%
SYRE - ENSC
31%
Poorly correlated
-5.21%
More

NEUP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEUP has been loosely correlated with SYBX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NEUP jumps, then SYBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEUP
1D Price
Change %
NEUP100%
-1.04%
SYBX - NEUP
64%
Loosely correlated
-1.61%
BRNS - NEUP
50%
Loosely correlated
-17.27%
ENSC - NEUP
31%
Poorly correlated
-2.34%
CMND - NEUP
30%
Poorly correlated
-0.48%
ZVSA - NEUP
27%
Poorly correlated
-6.54%
More